GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hansa Biopharma HNSA.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

41.30

+4.66%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Hansa Biopharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 222.3mSEK 171.3mSEK 134.1mSEK 154.5mSEK 33.9m
Operating income−SEK 520.7m−SEK 670.1m−SEK 725.3m−SEK 575.1m−SEK 547.5m
Net income−SEK 534.1m−SEK 807.2m−SEK 831.7m−SEK 611.1m−SEK 548.3m
Free cash flow−SEK 549.2m−SEK 675.0m−SEK 755.9m−SEK 506.1m−SEK 483.6m
Total assetsSEK 1.17bnSEK 800.6mSEK 1.02bnSEK 1.69bnSEK 1.01bn
Shareholders' equity−SEK 89.0m−SEK 589.8m−SEK 167.9mSEK 602.9mSEK 757.6m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.